{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:40:57Z","timestamp":1780368057674,"version":"3.54.1"},"reference-count":35,"publisher":"Archives of Endocrinology and Metabolism","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,5]]},"DOI":"10.20945\/2359-3997000000242","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T20:24:23Z","timestamp":1592339063000},"page":"235-242","source":"Crossref","is-referenced-by-count":13,"title":["Nonalcoholic fatty liver disease in women with polycystic ovary syndrome: associated factors and noninvasive fibrosis staging in a single Brazilian center"],"prefix":"10.20945","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6641-1350","authenticated-orcid":false,"given":"Daniela Oliveira de Lima","family":"Taranto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1014-0296","authenticated-orcid":false,"given":"Thais Cristine Moura","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9776-4757","authenticated-orcid":false,"given":"Claudia A.","family":"Couto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9080-2319","authenticated-orcid":false,"given":"Ana L\u00facia","family":"C\u00e2ndido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4676-7672","authenticated-orcid":false,"given":"Rosana Correa Silva","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4364-7472","authenticated-orcid":false,"given":"Fernanda Souza","family":"Mattos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4504-4069","authenticated-orcid":false,"given":"Maria Luiza C\u00e2ndido","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9258-7472","authenticated-orcid":false,"given":"Fernando M.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4717-9541","authenticated-orcid":false,"given":"Ana Luiza L.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0226-3491","authenticated-orcid":false,"given":"Luciana C.","family":"Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"key":"key20200616162415_B1","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/j.gastro.2016.03.005","article-title":"Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality","volume":"150","author":"Younossi","year":"2016","unstructured":"1. Younossi Z , Henry L . Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality . Gastroenterology . 2016 ; 150 : 1778 - 85 .","journal-title":"Gastroenterology"},{"key":"key20200616162415_B2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","unstructured":"2. Chalasani N , Younossi Z , Lavine JE , Charlton M , Cusi K , Rinella M , et al . The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases . Hepatology . 2018 ; 67 : 328 - 57 .","journal-title":"Hepatology"},{"key":"key20200616162415_B3","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/humupd\/dmy022","article-title":"Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"24","author":"Skiba","year":"2018","unstructured":"3. Skiba MA , Islam RM , Bell RJ , Davis SR . Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis . Hum Reprod Update . 2018 ; 24 : 694 - 709 .","journal-title":"Hum Reprod Update"},{"key":"key20200616162415_B4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and Predictors of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome","volume":"91","author":"Ehrmann","year":"2006","unstructured":"4. Ehrmann DA , Liljenquist DR , Kasza K , Legro RS , Ghazzi MN . Prevalence and Predictors of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome . J Clin Endocrinol Metab . 2006 ; 91 : 48 - 53 .","journal-title":"J Clin Endocrinol Metab"},{"key":"key20200616162415_B5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11892-006-0056-1","article-title":"Risk of T2DM and impaired fasting glucose among PCOS subjects: Results of an 8-year follow-up","volume":"6","author":"Boureaux","year":"2006","unstructured":"5. Boureaux MY , Talbott EO , Kip KE , Brooks MM , Witchel SF . Risk of T2DM and impaired fasting glucose among PCOS subjects: Results of an 8-year follow-up . Curr Diab Rep . 2006 ; 6 : 77 - 83 .","journal-title":"Curr Diab Rep"},{"key":"key20200616162415_B6","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s40618-017-0708-9","article-title":"Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis","volume":"40","author":"Rocha","year":"2017","unstructured":"6. Rocha ALL , Faria LC , Guimar\u00e3es TCM , Moreira GV , Candido AL , Couto CA , et al . Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis . J Endocrinol Invest . 2017 ; 40 : 1279 - 88 .","journal-title":"J Endocrinol Invest"},{"key":"key20200616162415_B7","first-page":"4259","article-title":"Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease","volume":"15","author":"Zhang","year":"2018","unstructured":"7. Zhang J , HU J , Zhang C , Jiao Y , Kong X , Wang W . Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease . Exp Ther Med . 2018 ; 15 : 4259 - 64 .","journal-title":"Exp Ther Med"},{"key":"key20200616162415_B8","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2009-2698","article-title":"Hyperandrogenemia Is Independently Associated with Elevated Alanine Aminotransferase Activity in Young Women with Polycystic Ovary Syndrome","volume":"95","author":"Chen","year":"2010","unstructured":"8. Chen MJ , Chiu HM , Yang WS , Yang YS , HO HN . Hyperandrogenemia Is Independently Associated with Elevated Alanine Aminotransferase Activity in Young Women with Polycystic Ovary Syndrome . J Clin Endocrinol Metab . 2010 ; 95 : 3332 - 41 .","journal-title":"J Clin Endocrinol Metab"},{"key":"key20200616162415_B9","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1210\/jc.2012-1382","article-title":"Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance","volume":"97","author":"Jones","year":"2012","unstructured":"9. Jones H , Sprung VS , Pugh CJ , Daousi C , Irwin A , Aziz N , et al . Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance . J Clin Endocrinol Metab . 2012 ; 97 : 3709 - 16 .","journal-title":"J Clin Endocrinol Metab"},{"key":"key20200616162415_B10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","unstructured":"10. Angulo P , Kleiner DE , Dam-Larsen S , Adams LA , Bjornsson ES , Charatcharoenwitthaya P , et al . Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease . Gastroenterology . 2015 ; 149 : 389 - 97 .","journal-title":"Gastroenterology"},{"key":"key20200616162415_B11","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","unstructured":"11. Sterling RK , Lissen E , Clumeck N , Sola R , Correa MC , Montaner J , et al . Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection . Hepatology . 2006 ; 43 : 1317 - 25 .","journal-title":"Hepatology"},{"key":"key20200616162415_B12","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","unstructured":"12. Angulo P , Hui JM , Marchesini , G , Bugianesi E , George J , Farrell GC , et al . The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD . Hepatology . 2007 ; 45 : 846 - 54 .","journal-title":"Hepatology"},{"key":"key20200616162415_B13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Fauser","year":"2004","unstructured":"13. Fauser BCJM . Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome . Fertil Steril . 2004 ; 81 : 19 - 25 .","journal-title":"Fertil Steril"},{"key":"key20200616162415_B14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","article-title":"Hirsutism: Implications, etiology, and management","volume":"140","author":"Hatch","year":"1981","unstructured":"14. Hatch R , Rosenfield RL , Kim MH , Tredway , D . Hirsutism: Implications, etiology, and management . Am J Obstet Gynecol . 1981 ; 140 : 815 - 30 .","journal-title":"Am J Obstet Gynecol"},{"key":"key20200616162415_B15","first-page":"1","article-title":"National Institute of Health Evidence-based Methodology Workshop on Polycystic Ovary Syndrome","author":"Johnson","year":"2012","unstructured":"15. Johnson TRB , Kaplan , LK , Ouyang P , Rizza RA . National Institute of Health Evidence-based Methodology Workshop on Polycystic Ovary Syndrome . Nat Institutes Heal . 2012 ; 1 - 14 .","journal-title":"Nat Institutes Heal"},{"key":"key20200616162415_B16","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome \u2013 A new worldwide definition","volume":"366","author":"Alberti","year":"2005","unstructured":"16. Alberti KG , Zimmet P , Shaw J . The metabolic syndrome \u2013 A new worldwide definition . Lancet . 2005 ; 366 : 1059 - 62 .","journal-title":"Lancet"},{"issue":"3","key":"key20200616162415_B17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2337\/dc07-9920","article-title":"Impaired Fasting Glucose and Impaired Glucose Tolerance. Implications for care","volume":"30","author":"Nathan","year":"2007","unstructured":"17. Nathan DM , Davidson MB , DeFronzo RA , Heine RJ , Henry RR , Pratley R , et al . Impaired Fasting Glucose and Impaired Glucose Tolerance. Implications for care . Diabetes Care . 2007 ; 30 ( 3 ): 753 - 59 .","journal-title":"Diabetes Care"},{"issue":"2","key":"key20200616162415_B18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.diabres.2005.10.017","article-title":"The threshold value for insulin resistance (HOMA-IR) in an admixture population IR in the Brazilian Metabolic Syndrome Study","volume":"72","author":"Geloneze","year":"2006","unstructured":"18. Geloneze B , Repetto EM , Geloneze SR , Tambascia MA , Ermetice MN . The threshold value for insulin resistance (HOMA-IR) in an admixture population IR in the Brazilian Metabolic Syndrome Study . Diabetes Res Clin Pract . 2006 ; 72 ( 2 ): 219 - 20 .","journal-title":"Diabetes Res Clin Pract"},{"key":"key20200616162415_B19","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/humrep\/dep072","article-title":"Lipid accumulation product index: A reliable marker of cardiovascular risk in polycystic ovary syndrome","volume":"24","author":"Wiltgen","year":"2009","unstructured":"19. Wiltgen , D , Benedetto IG , Mastella LS , Spritzer PM . Lipid accumulation product index: A reliable marker of cardiovascular risk in polycystic ovary syndrome . Hum Reprod . 2009 ; 24 : 1726 - 31 .","journal-title":"Hum Reprod"},{"key":"key20200616162415_B20","doi-asserted-by":"crossref","first-page":"825","DOI":"10.17219\/acem\/61100","article-title":"Usefulness of a new anthropometric indicator \u2013 VAI (Visceral Adiposity Index) in the evaluation of metabolic and hormonal disorders in women with polycystic ovary syndrome","volume":"26","author":"Bron8czyk-Puzon8","year":"2017","unstructured":"20. Bron8czyk-Puzon8 A , Jagielski P , Kulik-Kupka K , Koszowska A , Nowak , J , Zubelewicz-Szkodzin8ska B . Usefulness of a new anthropometric indicator \u2013 VAI (Visceral Adiposity Index) in the evaluation of metabolic and hormonal disorders in women with polycystic ovary syndrome . Adv Clin Exp Med . 2017 ; 26 : 825 - 28 .","journal-title":"Adv Clin Exp Med"},{"key":"key20200616162415_B21","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","article-title":"Non-invasive evaluation of liver fibrosis using transient elastography","volume":"48","author":"Castera","year":"2008","unstructured":"21. Castera L , Forns X , Alberti A . Non-invasive evaluation of liver fibrosis using transient elastography . J Hepatol . 2008 ; 48 : 835 - 47 .","journal-title":"J Hepatol"},{"key":"key20200616162415_B22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","article-title":"Non-invasive assesmente of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers","volume":"68","author":"Vilar-Gomez","year":"2017","unstructured":"22. Vilar-Gomez , Chalasani N . Non-invasive assesmente of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers . J Hepatol . 2017 ; 68 : 305 - 15 .","journal-title":"J Hepatol"},{"key":"key20200616162415_B23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1590\/S0004-28032015000200008","article-title":"Prevalence of Non-Alcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome and Its Correlation With Metabolic Syndrome","volume":"52","author":"Romanowski","year":"2015","unstructured":"23. Romanowski MD , Parolin MB , Freitas AC , Piazza MJ , Basso J , Urbanetz AA . Prevalence of Non-Alcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome and Its Correlation With Metabolic Syndrome . Arq. Gastroenterol . 2015 ; 52 : 117 - 23 .","journal-title":"Arq. Gastroenterol"},{"key":"key20200616162415_B24","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.steroids.2013.04.006","article-title":"Ethnic differences in the phenotypic expression of polycystic ovary syndrome","volume":"78","author":"Zhao","year":"2013","unstructured":"24. Zhao Y , Qiao J . Ethnic differences in the phenotypic expression of polycystic ovary syndrome . Steroids . 2013 ; 78 : 755 - 60 .","journal-title":"Steroids"},{"key":"key20200616162415_B25","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/apt.14058","article-title":"Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease","volume":"45","author":"Kim","year":"2017","unstructured":"25. Kim JJ , Kim D , Yim JY , Kang JH , Han KH , Kim SM , et al . Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease . Aliment Pharmacol Ther . 2017 ; 45 : 1403 - 12 .","journal-title":"Aliment Pharmacol Ther"},{"key":"key20200616162415_B26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1002542","article-title":"Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database","volume":"15","author":"Kumarendran","year":"2018","unstructured":"26. Kumarendran B , O\u2019Reilly MW , Manolopoulos KN , Toulis KA , Gokhale KM , Sitch AJ , et al . Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database . PLoS Med . 2018 ; 15 : 1 - 20 .","journal-title":"PLoS Med"},{"key":"key20200616162415_B27","first-page":"4259","article-title":"Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease","volume":"15","author":"Zhang","year":"2018","unstructured":"27. Zhang J , Hu J , Zhang C , Jiao Y , Kong X , Wang W . Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease . Exp Ther Med . 2018 ; 15 : 4259 - 64 .","journal-title":"Exp Ther Med"},{"key":"key20200616162415_B28","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","unstructured":"28. Marchesini G , Bugianesi E , Forlani G , Cerrelli F , Lenzi M , Manini R , et al . Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome . Hepatology . 2003 ; 37 : 917 - 23 .","journal-title":"Hepatology"},{"key":"key20200616162415_B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2261-5-26","article-title":"The \u2018lipid accumulation product\u2019 performs better than the body mass index for recognizing cardiovascular risk: A population-based comparison","volume":"5","author":"Kahn","year":"2005","unstructured":"29. Kahn HS . The \u2018lipid accumulation product\u2019 performs better than the body mass index for recognizing cardiovascular risk: A population-based comparison . BMC Cardiovasc Disord . 2005 ; 5 : 1 - 10 .","journal-title":"BMC Cardiovasc Disord"},{"key":"key20200616162415_B30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/09513590.2015.1111327","article-title":"Visceral adiposity index as a predictor of clinical severity and therapeutic outcome of PCOS","volume":"32","author":"Zheng","year":"2016","unstructured":"30. Zheng SH , Li XL . Visceral adiposity index as a predictor of clinical severity and therapeutic outcome of PCOS . Gynecol Endocrinol . 2016 ; 32 : 177 - 83 .","journal-title":"Gynecol Endocrinol"},{"key":"key20200616162415_B31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/humrep\/dep380","article-title":"Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"25","author":"Vassilatou","year":"2010","unstructured":"31. Vassilatou E , Lafoyianni S , Vryonidou A , Ioannidis D , Kosma L , Katsoulis K , et al . Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome . Hum Reprod . 2010 ; 25 : 212 - 20 .","journal-title":"Hum Reprod"},{"key":"key20200616162415_B32","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/humrep\/deq310","article-title":"Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): Results of a large database from a specialist Endocrine Clinic","volume":"26","author":"Wijeyaratne","year":"2011","unstructured":"32. Wijeyaratne CN , Seneviratne Rde A , Dahanayake S , Kumarapeli V , Palipane E , Kuruppu N , et al . Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): Results of a large database from a specialist Endocrine Clinic . Hum Reprod . 2011 ; 26 : 202 - 13 .","journal-title":"Hum Reprod"},{"key":"key20200616162415_B33","first-page":"519","article-title":"Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis","volume":"13","author":"Polyzos","year":"2014","unstructured":"33. Polyzos SA , Goulis DG , Kountouras J , Mintziori G , Chatzis P , Papadakis E , et al . Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis . Hormones ( Athens ). 2014 ; 13 : 519 - 31 .","journal-title":"Hormones"},{"key":"key20200616162415_B34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.18314\/cogo.v1i1.999","article-title":"The Association of Hispanic Ethnicity with Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome","volume":"1","author":"Sarkar","year":"2018","unstructured":"34. Sarkar M , Terrault N , Duwaerts CC , Tien P , Cedars MI , Huddleston H . The Association of Hispanic Ethnicity with Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome . Curr Opin Gynecol Obs . 2018 ; 1 : 24 - 33 .","journal-title":"Curr Opin Gynecol Obs"},{"key":"key20200616162415_B35","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.fertnstert.2017.04.011","article-title":"Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome","volume":"107","author":"Dokras","year":"2017","unstructured":"35. Dokras A , Saini S , Gibson-Helm M , Schulkin J , Cooney L , Teede H . Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome . Fertil Steril . 2017 ; 107 : 1380 - 6 .","journal-title":"Fertil Steril"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T20:24:36Z","timestamp":1592339076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2359-39972020000300235&lng=en&nrm=iso"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6,5]]}},"alternative-id":["10.20945\/2359-3997000000242"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000242","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}